Application

17829933 · 3-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione Derivatives and Uses thereof

Filed 2022-06-01 · Granted · Patent 12103919 (2024-10-01) The official file ↗The patent and its PDF ↗ · Art unit 1629 · Examiner Eric Tran Easy · CPC A61P 7/00 · NOVARTIS AG · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

12.4 mo

to disposition 28.0 mo

Statutes raised

112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.